No Data
Shenzhen Hepalink Pharmaceutical Gets US Distribution License for Anticonvulsant Drug
Hepalink Partners With Yongtai for U.S. Gabapentin Market
HEPALINK (09989.HK) signed a distribution agreement with Yongtai Pharmaceutical.
On January 2, Gelonghui reported that HEPALINK (09989.HK) announced that it had signed a distribution agreement with Zhejiang Yongtai Pharmaceutical Co., Ltd. ("Yongtai Pharmaceutical") on December 31, 2024, under which Yongtai Pharmaceutical granted the company the license to commercialize Gabapentin capsules ("symbol pharmaceutical") throughout the USA. According to the agreement, the company will purchase the symbol pharmaceutical from Yongtai Pharmaceutical at an agreed price and will be responsible for the commercialization of the symbol pharmaceutical in the USA. Aside from the supply price for the symbol pharmaceutical explicitly stated in the agreement, the company is not required to pay any additional amounts to Yongtai Pharmaceutical.
Express News | Shenzhen Hepalink Pharmaceutical - Yongtai Pharmaceutical to Grant Co License to Commercialize Gabapentin Capsules in US
Express News | Shenzhen Hepalink Pharmaceutical Group Co Ltd - Entering Into Distribution Agreement With Yongtai Pharmaceutical
How is the quality and supply of Pharmaceuticals guaranteed? The National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals.
On December 26, 2024, the National Healthcare Security Administration held a symposium on centralized procurement of Pharmaceuticals, inviting representatives from the National Medical Products Administration, selected Pharmaceutical enterprises, and research Institutions to communicate and exchange views on recent societal concerns regarding quality assurance of centrally procured Pharmaceuticals and innovative development in the Industry, and to listen to opinions and suggestions.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE:002399) Stocks Pounded By 35% But Not Lagging Market On Growth Or Pricing
No Data
